論文

筆頭著者 国際誌
2010年3月5日

The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

Cell
  • Paul L Greer
  • Rikinari Hanayama (co-1st author)
  • Brenda L Bloodgood
  • Alan R Mardinly
  • David M Lipton
  • Steven W Flavell
  • Tae-Kyung Kim
  • Eric C Griffith
  • Zachary Waldon
  • Rene Maehr
  • Hidde L Ploegh
  • Shoaib Chowdhury
  • Paul F Worley
  • Judith Steen
  • Michael E Greenberg
  • 全て表示

140
5
開始ページ
704
終了ページ
16
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.cell.2010.01.026

Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.

リンク情報
DOI
https://doi.org/10.1016/j.cell.2010.01.026
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/20211139
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843143
ID情報
  • DOI : 10.1016/j.cell.2010.01.026
  • PubMed ID : 20211139
  • PubMed Central 記事ID : PMC2843143

エクスポート
BibTeX RIS